Virios Therapeutics Inc (VIRI)
Virios Therapeutics Market Cap: 6.767M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 6.767M |
May 16, 2024 | 7.434M |
May 15, 2024 | 7.828M |
May 14, 2024 | 7.355M |
May 13, 2024 | 6.819M |
May 10, 2024 | 6.835M |
May 09, 2024 | 7.176M |
May 08, 2024 | 8.262M |
May 07, 2024 | 7.954M |
May 06, 2024 | 7.896M |
May 03, 2024 | 7.925M |
May 02, 2024 | 8.111M |
May 01, 2024 | 8.472M |
April 30, 2024 | 8.704M |
April 29, 2024 | 9.047M |
April 26, 2024 | 9.042M |
April 25, 2024 | 8.778M |
April 24, 2024 | 8.188M |
April 23, 2024 | 8.300M |
April 22, 2024 | 8.198M |
April 19, 2024 | 8.387M |
April 18, 2024 | 8.664M |
April 17, 2024 | 8.683M |
April 16, 2024 | 8.705M |
April 15, 2024 | 9.070M |
Date | Value |
---|---|
April 12, 2024 | 9.868M |
April 11, 2024 | 9.242M |
April 10, 2024 | 8.955M |
April 09, 2024 | 8.943M |
April 08, 2024 | 8.676M |
April 05, 2024 | 8.820M |
April 04, 2024 | 9.263M |
April 03, 2024 | 9.475M |
April 02, 2024 | 10.40M |
April 01, 2024 | 11.17M |
March 28, 2024 | 9.226M |
March 27, 2024 | 9.315M |
March 26, 2024 | 8.283M |
March 25, 2024 | 9.047M |
March 22, 2024 | 8.809M |
March 21, 2024 | 6.388M |
March 20, 2024 | 6.760M |
March 19, 2024 | 6.817M |
March 18, 2024 | 6.162M |
March 15, 2024 | 6.124M |
March 14, 2024 | 6.353M |
March 13, 2024 | 6.047M |
March 12, 2024 | 6.047M |
March 11, 2024 | 7.096M |
March 08, 2024 | 7.106M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
CEL-SCI Corp | 68.78M |
AIM ImmunoTech Inc | 20.11M |
IGC Pharma Inc | 35.69M |
NovaBay Pharmaceuticals Inc | 4.487M |
Protalix BioTherapeutics Inc | 83.58M |
Market Cap Related Metrics
Price to Book Value | 2.549 |
Price | 0.3514 |
Earnings Yield | -76.84% |